Atara Biotherapeutics Inc... (ATRA)
NASDAQ: ATRA
· Real-Time Price · USD
12.24
0.52 (4.44%)
At close: Aug 15, 2025, 3:59 PM
12.74
4.08%
After-hours: Aug 15, 2025, 07:47 PM EDT
Atara Biotherapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 16.9M | 13.84M | 25.03M | 46.45M | 31.31M | 35.23M | 25.99M | 64.79M | 45.9M | 48.74M | 92.94M | 65.11M | 70.69M | 101.67M | 106.08M | 113.21M | 123.86M | 151.1M |
Short-Term Investments | 5.42M | n/a | 17.47M | 20.74M | 3.98M | 11.15M | 25.88M | 37.62M | 107.74M | 156.67M | 149.88M | 200.29M | 260.62M | 200.14M | 264.98M | 244.04M | 249.52M | 284.06M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.2M | 1.2M | 1.2M | 1.2M | 1.2M |
Other Long-Term Assets | 927K | 2.84M | 3.1M | 3.36M | 3.61M | 3.87M | 4.84M | 6.29M | 6.58M | 6.91M | 7.02M | 7.17M | 7.23M | 53.65M | 2.37M | 670K | 689K | 729K |
Receivables | n/a | 8.88M | 1.48M | 1.33M | 2.42M | 35.83M | 34.11M | 163K | 507K | 397K | 40.22M | 249K | 637K | 668K | 986K | n/a | n/a | 9.61M |
Inventory | n/a | n/a | 10.65M | 13.98M | 18.75M | 16.08M | 9.71M | 6.59M | 7.86M | 5.34M | 1.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 2.45M | 4.47M | 10.26M | 9.35M | 5.95M | 8.28M | 6.33M | 9.53M | 10.31M | 13.04M | 10.45M | 2.15M | 2.25M | 936K | 12.57M | 594K | 894K | 894K |
Total Current Assets | 24.77M | 27.18M | 64.89M | 91.86M | 62.41M | 106.43M | 101.87M | 118.7M | 172.32M | 224.18M | 295.08M | 283.05M | 346.98M | 314.39M | 384.62M | 369.5M | 392.32M | 464.31M |
Property-Plant & Equipment | 11.2M | 32.01M | 41.1M | 47.49M | 51.27M | 54.97M | 58.79M | 63.8M | 67.54M | 71M | 74.32M | 78.1M | 81.91M | 28.04M | 79.94M | 78.56M | 62.58M | 63.4M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 12.13M | 34.86M | 44.2M | 50.85M | 54.87M | 58.84M | 63.63M | 70.09M | 74.12M | 77.9M | 81.34M | 85.27M | 89.14M | 82.89M | 83.51M | 80.43M | 64.47M | 65.33M |
Total Assets | 36.9M | 62.04M | 109.1M | 142.71M | 117.28M | 165.27M | 165.5M | 188.79M | 246.44M | 302.08M | 376.42M | 368.32M | 436.12M | 397.28M | 468.13M | 449.92M | 456.79M | 529.64M |
Account Payables | 1.76M | 1.38M | 4.37M | 2.15M | 5.25M | 2.85M | 3.68M | 6.51M | 4.14M | 5.07M | 6.87M | 11.3M | 12.8M | 11.95M | 17.37M | 16.54M | 12.3M | 17.36M |
Deferred Revenue | 1.61M | 15.98M | 95.09M | 116.34M | 107.58M | 123.15M | 77.83M | 11.61M | 11.95M | 9.92M | 8M | 2.66M | 1.67M | 50.94M | 40.76M | 31.23M | 40.97M | 35.5M |
Short-Term Debt | n/a | 14.4M | 13.92M | 15.25M | n/a | n/a | n/a | n/a | n/a | 12.61M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 12.96M | 2.2M | -7.33M | -187K | 7.27M | 5.71M | 37.01M | 33.24M | 32.95M | 18.75M | 32.75M | 40.42M | 34.9M | 22.29M | 19.75M | 19.24M | 20.24M | 18.56M |
Total Current Liabilities | 14.56M | 47.89M | 134.57M | 155.98M | 148.27M | 180.69M | 142.23M | 79.09M | 74.55M | 67.88M | 78.92M | 72.24M | 65.69M | 101.56M | 105.79M | 86.15M | 88.83M | 84.19M |
Long-Term Debt | 15.43M | n/a | n/a | n/a | 36.45M | 35.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 41.95M | 42.51M | 41.89M | 41.55M | 4.17M | 4.4M | 39.25M | 38.1M | 37.11M | 36.29M | 35.8M | 5.55M | 5.63M | 8.95M | 1.5M | 2.21M | 1.77M | 2.03M |
Total Long-Term Liabilities | 57.38M | 69.22M | 71.81M | 77.27M | 79.89M | 82.89M | 122.51M | 160.54M | 164.43M | 169.25M | 170.86M | 108.96M | 112.95M | 71.4M | 82.73M | 53.63M | 36.42M | 46.41M |
Total Liabilities | 71.94M | 117.11M | 206.38M | 233.25M | 228.15M | 263.58M | 264.74M | 239.63M | 238.99M | 237.12M | 249.78M | 181.2M | 178.64M | 172.96M | 188.51M | 139.78M | 125.25M | 130.6M |
Total Debt | 15.43M | 80.5M | 43.83M | 49.9M | 52.7M | 92.34M | 57.87M | 61.8M | 64.71M | 54.92M | 71.7M | 61.07M | 64M | 17.45M | 25.52M | 24.57M | 12.18M | 12.57M |
Common Stock | 1K | 1K | 1K | 1K | n/a | 12K | 11K | 10K | 10K | 10K | 10K | 9K | 9K | 9K | 9K | 9K | 8K | 8K |
Retained Earnings | -2.01B | -2.02B | -2.05B | -2.04B | -2.02B | -2B | -1.97B | -1.91B | -1.84B | -1.77B | -1.69B | -1.62B | -1.53B | -1.55B | -1.46B | -1.37B | -1.29B | -1.2B |
Comprehensive Income | n/a | n/a | 8K | 22K | -14K | -55K | -204K | -571K | -933K | -1.24M | -2.07M | -2.96M | -2.62M | -1.89M | -368K | 24K | 62K | 161K |
Shareholders Equity | -35.04M | -55.07M | -97.28M | -90.54M | -110.87M | -98.31M | -99.23M | -50.84M | 7.45M | 64.96M | 126.64M | 187.11M | 257.48M | 224.32M | 279.61M | 310.14M | 331.54M | 399.04M |
Total Investments | n/a | n/a | 17.47M | 20.74M | 3.98M | 11.15M | 25.88M | 37.62M | 107.74M | 156.67M | 149.88M | 200.29M | 260.62M | 200.14M | 264.98M | 244.04M | 249.52M | 284.06M |